.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
BPL Medical Technologies recently completed the acquisition of Yozma BMtech. This strategic move introduces advanced bone mineral density diagnostics to the Indian market. Consequently, healthcare providers can now better address the rising prevalence of osteoporosis. Furthermore, the collaboration combines South Korean innovation with BPL's extensive distribution network. These systems aim to improve clinical outcomes through early detection and monitoring.
The newly launched systems utilize high-speed scanning and high-resolution imaging. Specifically, fan-beam technology with multi-channel detectors improves measurement accuracy across various anatomical sites. These devices minimize geometrical distortion even during whole-body densitometry. Additionally, the low-radiation design ensures patient safety during routine screenings. These compact machines also fit well in space-constrained diagnostic centers. Consequently, more hospitals can offer specialized bone health services.
Osteoporosis remains a significant public health challenge for the aging Indian population. Research indicates that over 80% of postmenopausal women may suffer from low bone mass. Therefore, early detection through precise screening is essential for preventing fragility fractures. BPL's new portfolio specifically targets the women's health segment. Moreover, these solutions facilitate better monitoring of lifestyle-related bone health risks. This expansion strengthens BPL's position in the preventive healthcare ecosystem.
Q1: What is the primary benefit of fan-beam technology in BMD scans?
Fan-beam technology reduces geometrical distortion and magnification errors, providing more accurate measurements of bone mineral content and size compared to older pencil-beam systems.
Q2: Why is bone mineral density screening critical for postmenopausal women?
Postmenopausal women face a higher risk of bone loss due to estrogen deficiency. Early screening identifies osteopenia or osteoporosis, allowing for timely intervention to prevent fractures.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
BPL Medical Technologies acquires Yozma BMtech to launch advanced bone mineral density diagnostics for early osteoporosis screening in India and Dubai....
5 months ago
Explore evidence-based tobacco cessation strategies tailored for low- and middle-income countries. Learn about the Ask-Advise-Connect model, WHO EML pharmacotherapy, and digital interventions to improve clinical outcomes.
Today
A multicenter MPOG database study of 289,047 cesarean delivery cases analyzed adherence to obstetric anesthesia best practices. General anesthesia avoidance reached 97.0%, while post-spinal vasopressor infusions (55.4%) and hypothermia prevention (56.7%) showed the lowest compliance, highlighting key targets.
Today
A landmark study analyzing over 56,000 adult health records in Delhi-NCR reveals that hypertension and diabetes coexistence affects nearly 5% of adults. The prevalence doubles expected rates and rises sharply after age 40. Early integrated screening is essential to prevent microvascular and macrovascular complications.
Today
Researchers developed a Haversian-inspired composite scaffold that addresses delayed vascularization and wet-state mechanical deterioration in critical bone defect repair. By integrating spatially programmed calcium phosphate minerals and selective silica reinforcement, the design promotes vascularized bone repair.
2 days back
A comprehensive observational analysis evaluates the impact of preoperative GLP-1 RA use on 14-day postoperative mortality, respiratory complications, and major adverse cardiovascular events compared to other antidiabetic therapies.
Today
